Cargando…

Safety and immunogenicity of an mRNA-lipid nanoparticle vaccine candidate against SARS-CoV-2: A phase 1 randomized clinical trial

BACKGROUND: We used the RNActive® technology platform (CureVac N.V., Tübingen, Germany) to prepare CVnCoV, a COVID-19 vaccine containing sequence-optimized mRNA coding for a stabilized form of SARS-CoV‑2 spike (S) protein encapsulated in lipid nanoparticles (LNP). METHODS: This is an interim analysi...

Descripción completa

Detalles Bibliográficos
Autores principales:	Kremsner, Peter G., Mann, Philipp, Kroidl, Arne, Leroux-Roels, Isabel, Schindler, Christoph, Gabor, Julian J., Schunk, Mirjam, Leroux-Roels, Geert, Bosch, Jacobus J., Fendel, Rolf, Kreidenweiss, Andrea, Velavan, Thirumalaisamy P., Fotin-Mleczek, Mariola, Mueller, Stefan O., Quintini, Gianluca, Schönborn‑Kellenberger, Oliver, Vahrenhorst, Dominik, Verstraeten, Thomas, Alves de Mesquita, Margarida, Walz, Lisa, Wolz, Olaf‑Oliver, Oostvogels, Lidia
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Springer Vienna 2021
Materias:	Original Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8354521/ https://www.ncbi.nlm.nih.gov/pubmed/34378087 http://dx.doi.org/10.1007/s00508-021-01922-y

Ejemplares similares

Proof-of-concept of a low-dose unmodified mRNA-based rabies vaccine formulated with lipid nanoparticles in human volunteers: A phase 1 trial
por: Aldrich, Cassandra, et al.
Publicado: (2021)

Broad Clade 2 Cross-Reactive Immunity Induced by an Adjuvanted Clade 1 rH5N1 Pandemic Influenza Vaccine
por: Leroux-Roels, Isabel, et al.
Publicado: (2008)

The role of cell-mediated immunity against influenza and its implications for vaccine evaluation
por: Janssens, Yorick, et al.
Publicado: (2022)

Safety and immunogenicity of mRNA-LNP COVID-19 vaccine CVnCoV in Latin American adults: A phase 2 randomized study
por: Sáez-Llorens, Xavier, et al.
Publicado: (2022)

Corrigendum to “Safety and immunogenicity of mRNA-LNP COVID-19 vaccine CVnCoV in Latin American adults: A phase 2 randomized study” [Vaccine: X 11 (2022) 100189]
por: Sáez-Llorens, Xavier, et al.
Publicado: (2023)

Detection of H1 Swine Influenza A Virus Antibodies in Human Serum Samples by Age Group
por: Vandoorn, Elien, et al.
Publicado: (2020)

Human Immunity and Susceptibility to Influenza A(H3) Viruses of Avian, Equine, and Swine Origin
por: Vandoorn, Elien, et al.
Publicado: (2023)

HCV Animal Models: A Journey of More than 30 Years
por: Meuleman, Philip, et al.
Publicado: (2009)

Double-Blind, Placebo-Controlled, Dose-Escalating Study Evaluating the Safety and Immunogenicity of an Epitope-Specific Chemically Defined Nanoparticle RSV Vaccine
por: Leroux-Roels, Isabel, et al.
Publicado: (2023)

Immune responses in healthy adults elicited by a bivalent norovirus vaccine candidate composed of GI.4 and GII.4 VLPs without adjuvant
por: Waerlop, Gwenn, et al.
Publicado: (2023)

Longitudinal Monitoring of Lactate in Hospitalized and Ambulatory COVID-19 Patients
por: Velavan, Thirumalaisamy P., et al.
Publicado: (2021)

Testing a compact mobile air purification unit, does it do the job
por: De Waegemaeker, P, et al.
Publicado: (2015)

H5N1 Influenza Vaccine Formulated with AS03(A) Induces Strong Cross-Reactive and Polyfunctional CD4 T-Cell Responses
por: Moris, Philippe, et al.
Publicado: (2010)

Self-adjuvanted RNActive(® )vaccines provide a promising platform for combination therapies with checkpoint inhibitors
por: Kowalczyk, Aleksandra, et al.
Publicado: (2014)

Safety and immunogenicity of a new Sabin inactivated poliovirus vaccine candidate produced on the PER.C6® cell-line: a phase 1 randomized controlled trial in adults
por: Leroux-Roels, Isabel, et al.
Publicado: (2020)

Antibody Persistence and Booster Responses to Split-Virion H5N1 Avian Influenza Vaccine in Young and Elderly Adults
por: Lazarus, Rajeka, et al.
Publicado: (2016)

A Third Dose of the COVID-19 Vaccine, CVnCoV, Increased the Neutralizing Activity against the SARS-CoV-2 Wild-Type and Delta Variant
por: Wolz, Olaf-Oliver, et al.
Publicado: (2022)

Immunogenicity and safety of different formulations of an adjuvanted glycoprotein D genital herpes vaccine in healthy adults: A double-blind randomized trial
por: Leroux-Roels, Geert, et al.
Publicado: (2013)

Randomized, Double-Blind, Reference-Controlled, Phase 2a Study Evaluating the Immunogenicity and Safety of OVX836, A Nucleoprotein-Based Influenza Vaccine
por: Leroux-Roels, Isabel, et al.
Publicado: (2022)

Herd immunity and vaccination of children for COVID-19
por: Velavan, Thirumalaisamy P., et al.
Publicado: (2020)

How to (ab)use a COVID-19 antigen rapid test with soft drinks?
por: Velavan, Thirumalaisamy P, et al.
Publicado: (2021)

mRNA-based SARS-CoV-2 vaccine candidate CVnCoV induces high levels of virus-neutralising antibodies and mediates protection in rodents
por: Rauch, Susanne, et al.
Publicado: (2021)

LB13. Trivalent Hepatitis B (HepB) Vaccine Yields Superior Seroprotection Rates in Adults: Results from the Phase 3 Double-Blind, Randomized Study Comparing Immunogenicity and Safety of a 3-Dose Regimen of Sci-B-Vac™ and Engerix B® (PROTECT)
por: Vesikari, Timo, et al.
Publicado: (2019)

Efficacy and safety of the CVnCoV SARS-CoV-2 mRNA vaccine candidate in ten countries in Europe and Latin America (HERALD): a randomised, observer-blinded, placebo-controlled, phase 2b/3 trial
por: Kremsner, Peter G, et al.
Publicado: (2022)

Persistence and immune memory to hepatitis B vaccine 20 years after primary vaccination of Thai infants, born to HBsAg and HBeAg positive mothers
por: Poovorawan, Yong, et al.
Publicado: (2012)

Persistence of antibodies 20 y after vaccination with a combined hepatitis A and B vaccine
por: Van Damme, Pierre, et al.
Publicado: (2017)

A randomized, double-blind, placebo-controlled, dose-escalating phase I trial to evaluate safety and immunogenicity of a plant-produced, bivalent, recombinant norovirus-like particle vaccine
por: Leroux-Roels, Isabel, et al.
Publicado: (2022)

Lectin Complement Protein Collectin 11 (CL-K1) and Susceptibility to Urinary Schistosomiasis
por: Antony, Justin S., et al.
Publicado: (2015)

Evidence of protection against clinical and chronic hepatitis B infection 20 years after infant vaccination in a high endemicity region
por: Poovorawan, Y, et al.
Publicado: (2011)

Comparison of five SARS-CoV-2 rapid antigen detection tests in a hospital setting and performance of one antigen assay in routine practice: a useful tool to guide isolation precautions?
por: Van Honacker, E., et al.
Publicado: (2021)

mRNA-based vaccines synergize with radiation therapy to eradicate established tumors
por: Fotin-Mleczek, Mariola, et al.
Publicado: (2014)

Sequence-engineered mRNA Without Chemical Nucleoside Modifications Enables an Effective Protein Therapy in Large Animals
por: Thess, Andreas, et al.
Publicado: (2015)

Asymptomatic SARS Coronavirus 2 infection: Invisible yet invincible
por: Nikolai, Lea A., et al.
Publicado: (2020)

An alternative dogma on reduced artemisinin susceptibility: A new shadow from east to west
por: Velavan, Thirumalaisamy P., et al.
Publicado: (2019)

Self-adjuvanted RNActive(® )vaccine induces local immune responses at the injection site leading to potent adaptive immunity in mice and humans
por: Kowalczyk, Aleksandra, et al.
Publicado: (2014)

COVID-19 and syndemic challenges in ‘Battling the Big Three’: HIV, TB and malaria()
por: Velavan, Thirumalaisamy P., et al.
Publicado: (2021)

Non-Invasive Antibody Assessment in Saliva to Determine SARS-CoV-2 Exposure in Young Children
por: Heinzel, Constanze, et al.
Publicado: (2021)

Molecular detection and quantification of Plasmodium falciparum-infected human hepatocytes in chimeric immune-deficient mice
por: Foquet, Lander, et al.
Publicado: (2013)

Surveillance of Endoscopes: Comparison of Different Sampling Techniques
por: Cattoir, Lien, et al.
Publicado: (2017)

1531. A CMV Vaccine Based on Non-Replicating Lymphocytic Choriomeningitis Virus Vectors Expressing gB and pp65 Is Safe and Immunogenic in Healthy Volunteers, Allowing for Development of a Phase II Clinical Trial in Living Donor Kidney Transplant Recipients
por: Kotton, Camille Nelson, et al.
Publicado: (2018)

Cannot write session to /tmp/vufind_sessions/sess_v9oib74ns3g93741vpt06j3d4g